Literature DB >> 11071847

Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells.

A Junicho1, T Matsuda, T Yamamoto, H Kishi, K Korkmaz, F Saatcioglu, H Fuse, A Muraguchi.   

Abstract

Protein inhibitor of activated STAT3 (PIAS3) is a specific inhibitor of signal transducer and activator of transcription 3 (STAT3). PIAS3 binds to STAT3 and inhibits its DNA-binding activity, and thereby STAT3-mediated gene activation. PIAS1, another member of the PIAS family, was recently shown to interact with the androgen receptor (AR), a nuclear hormone receptor that has an important role in both physiological and pathological processes, and acts as a cofactor for AR. Here we demonstrate that PIAS3 is expressed in prostate cancer cells and its expression is induced in response to dihydrotestosterone (DHT) treatment. Ectopic overexpression of PIAS3 suppressed AR-mediated gene activation induced by DHT-stimulation in LNCaP cells. We provide evidence that these activities were due to direct physical interactions between PIAS3 and AR. These results indicate that PIAS3 acts as a coregulator of AR signaling pathway in prostate cancer cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11071847     DOI: 10.1006/bbrc.2000.3753

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.

Authors:  Darja Schmidt; Stefan Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

2.  Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.

Authors:  Amy Kluge; Snehal Dabir; Jeffrey Kern; David Nethery; Balazs Halmos; Patrick Ma; Afshin Dowlati
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

3.  PIAS3, an inhibitor of STAT3, has intensively negative association with the survival of gastric cancer.

Authors:  Jingwu Li; Jianzhong Cui; Jinghua Zhang; Yuanting Liu; Longcai Han; Chunliang Jia; Jingyu Deng; Han Liang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

4.  Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity.

Authors:  Shreeram C Nallar; Sudhakar Kalakonda; Peng Sun; Yoshihiro Ohmori; Miki Hiroi; Kazumasa Mori; Daniel J Lindner; Dhananjaya V Kalvakolanu
Journal:  Am J Pathol       Date:  2010-07-01       Impact factor: 4.307

Review 5.  Cytokine-induced tumor suppressors: a GRIM story.

Authors:  Dhan V Kalvakolanu; Shreeram C Nallar; Sudhakar Kalakonda
Journal:  Cytokine       Date:  2010-04-10       Impact factor: 3.861

6.  Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.

Authors:  Shreeram C Nallar; Sudhakar Kalakonda; Daniel J Lindner; Robert R Lorenz; Eric Lamarre; Xiao Weihua; Dhananjaya V Kalvakolanu
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

7.  The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3.

Authors:  Jun Zhang; Jinbo Yang; Sanjit K Roy; Silvia Tininini; Jiadi Hu; Jacqueline F Bromberg; Valeria Poli; George R Stark; Dhananjaya V Kalvakolanu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-16       Impact factor: 11.205

8.  Pias3-dependent SUMOylation directs rod photoreceptor development.

Authors:  Akishi Onishi; Guang-Hua Peng; Chengda Hsu; Uel Alexis; Shiming Chen; Seth Blackshaw
Journal:  Neuron       Date:  2009-01-29       Impact factor: 17.173

Review 9.  Signal transducer and activator of transcription 5A/B in prostate and breast cancers.

Authors:  Shyh-Han Tan; Marja T Nevalainen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

Review 10.  Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer.

Authors:  Zhiyong Liao; Jacqueline Lutz; Marja T Nevalainen
Journal:  Int J Biochem Cell Biol       Date:  2009-11-13       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.